Topline Results and Discussion of Phase 1 INTERCEPT-AD Trial Jul 17, 2023 at 8:00 AM EDT Click here for webcast Supporting Materials Investor Presentation Discussing Topline Results of Phase 1 INTERCEPT-AD Trial’ 1.3 MB